 |
|
Variation of Breast Cancer Risk Among BRCA1/2 Carriers
Colin B. Begg, PhD;
Robert W. Haile, DrPH;
Åke Borg, PhD;
Kathleen E. Malone, PhD;
Patrick Concannon, PhD;
Duncan C. Thomas, PhD;
Bryan Langholz, PhD;
Leslie Bernstein, PhD;
Jørgen H. Olsen, MD, DMSc;
Charles F. Lynch, MD, PhD;
Hoda Anton-Culver, PhD;
Marinela Capanu, PhD;
Xiaolin Liang, MD, MA;
Amanda J. Hummer, MS;
Cami Sima, MD, MS;
Jonine L. Bernstein, PhD
JAMA. 2008;299(2):194-201.
Context The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers.
Objectives To determine the extent to which risks for BRCA1 and BRCA2 carriers vary with respect to observable and unobservable characteristics.
Design, Setting, and Participants Probands were identified from a population-based, case-control study (Women’s Environmental Cancer and Radiation Epidemiology [WECARE]) of asynchronous contralateral breast cancer conducted during the period of January 2000 to July 2004. Participants previously diagnosed with contralateral breast cancer or unilateral breast cancer were genotyped for mutations in BRCA1 and BRCA2. All participants had their initial breast cancer diagnosed during the period of January 1985 to December 2000, before the age of 55 years.
Main Outcome Measure Incidence of breast cancer in first-degree female relatives of the probands was examined and compared on the basis of proband characteristics and on the basis of variation between families.
Results Among the 1394 participants with unilateral breast cancer, 73 (5.2%) were identified as carriers of deleterious mutations (42 with BRCA1 and 31 with BRCA2). Among the 704 participants with contralateral breast cancer, 108 (15.3%) were identified as carriers of deleterious mutations (67 with BRCA1 and 41 with BRCA2). Among relatives of carriers, risk was significantly associated with younger age at diagnosis in the proband (P = .04), and there was a trend toward higher risk for relatives of contralateral breast cancer vs unilateral breast cancer participants (odds ratio, 1.4 [95% confidence interval, 0.8-2.4]; P = .28). In addition, there were significant differences in risk between carrier families after adjusting for these observed characteristics.
Conclusion There exists broad variation in breast cancer risk among carriers of BRCA1 and BRCA2 mutations.
Author Affiliations: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York (Drs Begg, Capanu, Liang, Sima, and J. Bernstein and Ms Hummer); Department of Preventive Medicine, University of Southern California, Los Angeles (Drs Haile, Thomas, Langholz, and L. Bernstein); Department of Oncology, University Hospital, Lund, Sweden (Dr Borg); Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington (Dr Malone); Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville (Dr Concannon); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (Dr Olsen); Department of Epidemiology, University of Iowa, Iowa City (Dr Lynch); and Department of Medicine, University of California, Irvine (Dr Anton-Culver).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antoniou et al.
Hum Mol Genet 2009;18:4442-4456.
ABSTRACT
| FULL TEXT
Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer
Oeffinger et al.
JAMA 2009;301:404-414.
ABSTRACT
| FULL TEXT
Racial Disparity in Breast Cancer and Functional Germ Line Mutation in Galectin-3 (rs4644): A Pilot Study
Balan et al.
Cancer Res. 2008;68:10045-10050.
ABSTRACT
| FULL TEXT
Breast Cancer Incidence and the Effect of Cigarette Smoking in Heterozygous Carriers of Mutations in the Ataxia-Telangiectasia Gene
Swift and Lukin
Cancer Epidemiol. Biomarkers Prev. 2008;17:3188-3192.
ABSTRACT
| FULL TEXT
Performance of BRCA1/2 Mutation Prediction Models in Asian Americans
Kurian et al.
JCO 2008;26:4752-4758.
ABSTRACT
| FULL TEXT
Timing of Familial Breast Cancer in Sisters
Rebora et al.
JNCI J Natl Cancer Inst 2008;100:721-727.
ABSTRACT
| FULL TEXT
Polymorphisms in RAD51, XRCC2, and XRCC3 Are Not Related to Breast Cancer Risk
Brooks et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1016-1019.
FULL TEXT
BRCA1 and BRCA2: The More We Know About Risk, the Less We Know
JWatch Women's Health 2008;2008:3-3.
FULL TEXT
Variation in Breast Cancer Risk Among BRCA1 or 2 Carriers
JWatch Oncology and Hematology 2008;2008:1-1.
FULL TEXT
|
